Ankaferd blood stopper as a new strategy to avoid early complications after transradial procedures: A randomized clinical trial.

Ankaferd blood stopper is a promising device for use in patent hemostasis, with no evidence on RAO at short-term or long term and with reduced risk of re-bleeding at the end of hemostasis.